Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypical analysis, relation to malignancy and prognostic relevance of ICOS+T regulatory and dendritic cells in patients with gliomas.

Journal of neuroimmunology - 15 Nov 2013

Gousias Konstantinos, von Ruecker Alexander, Voulgari Paraskevi, Simon Matthias

Abstract excerpt

We determined circulating T helper, T regulatory and ICOS+T regulatory as well as DC cell counts in 29 patients with cerebral gliomas. Samples from patients with gliomas vs. healthy controls and from patients with glioblastomas vs. patients with glioma WHO grades I-III contained significantly (p<0.05) decreased numbers of total as well as mature, i.e. myeloid and plasmacytoid DCs. Patients with glioblastomas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Glioma

Share to Inducible T-Cell Co-Stimulator Protein

Share to Lymphocyte Activation

Share to Survival Analysis

Share to T-Lymphocytes, Regulatory

Source

Identifiers

PMID: 24071056
DOI: 10.1016/j.jneuroim.2013.09.001

Genes

ICOS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypical analysis, relation to malignancy and prognostic relevance of ICOS+T regulatory and dendritic cells in patients with gliomas.PMID 24071056Read ↗

Immune phenotypes predict survival in patients with glioblastoma multiformeSemantic proximity Read ↗

Brain tumor induce immunoregulatory dendritic cells in tumor draining lymph nodes that can be targeted by OX40Semantic proximity Read ↗

Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy VolunteersSemantic proximity Read ↗

Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccinationSemantic proximity Read ↗

Tumors Located in the Brain Impair the Frequency and Phenotype of Dendritic Cells in Blood and TumorSemantic proximity Read ↗

CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastomaSemantic proximity Read ↗

Tumor-specific neutrophils originating from meninges promote glioblastomaSemantic proximity Read ↗

Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or GliosarcomaSemantic proximity Read ↗

Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells.Semantic proximity Read ↗

Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.Semantic proximity Read ↗

Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.Semantic proximity Read ↗

Cellular immune response in brain tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.